Kiora Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Capital Stock (Details)

Capital Stock (Details)						1 Months Ended								3 Months Ended		9 Months Ended
Capital Stock (Details)	Jan. 31, 2024 USD ($) day $ / shares shares	Aug. 07, 2023 USD ($) day $ / shares shares	Jun. 06, 2023 USD ($) $ / shares shares	Feb. 22, 2023 USD ($) shares	Feb. 03, 2023 USD ($) $ / shares shares	Jun. 30, 2024 USD ($) $ / shares shares	Feb. 29, 2024 USD ($) $ / shares shares	Nov. 30, 2023 USD ($) shares	Aug. 31, 2023 shares	Jul. 31, 2023 shares	Jun. 30, 2023 shares	Apr. 30, 2023 USD ($) shares	Feb. 28, 2023 shares	Sep. 30, 2024 USD ($) shares	Sep. 30, 2023 USD ($)	Sep. 30, 2024 USD ($) shares	Sep. 30, 2023 USD ($)	Jun. 11, 2024 shares	May 01, 2024 shares	Dec. 31, 2023 shares
Class of Stock [Line Items]
Common stock, shares authorized (in shares)														150,000,000		150,000,000		150,000,000	150,000,000	50,000,000
Number of warrants issued to purchase the shares (in shares)																			5,486,066
Net proceeds \| $			$ 5,600,000
Underwriting discount and commissions \| $			500,000
Underwriting discount and commissions expenses \| $			$ 200,000
Class of warrant or right, outstanding (in shares)		1,277,778
Deemed dividend \| $		$ 500,000												$ 0	$ 530,985	$ 0	$ 530,985
Issuance of Common Stock from Warrant Exercises (in shares)													5,556
Exercise of Warrants \| $								$ 8,600								1,689,339	298,500
Gross Proceeds from Private Placement \| $																14,998,865	200,000
Proceeds from issuance of common stock, net of offering costs \| $																0	442,310
Public Offering
Class of Stock [Line Items]
Proceeds from issuance of common stock, net of offering costs \| $																$ 0	$ 6,325,000
Private Placement
Class of Stock [Line Items]
Number of warrants issued to purchase the shares (in shares)					11,733
Warrants and rights outstanding, term					5 years
Issuance of common stock (in shares)					5,866
Gross Proceeds from Private Placement \| $					$ 100,000
Private Placement \| Common Stock
Class of Stock [Line Items]
Exercise price (in usd per share) \| $ / shares					$ 31.842
Series F Convertible Preferred Stock
Class of Stock [Line Items]
Conversion of stock, shares converted (in shares)									59	59	329
Series F Convertible Preferred Stock \| Public Offering
Class of Stock [Line Items]
Convertible preferred stock, shares issued upon conversion (in shares)			434
Common Stock
Class of Stock [Line Items]
Convertible preferred stock, shares issued upon conversion (in shares)									53,530	53,530	298,758
Common Stock \| Over-Allotment Option
Class of Stock [Line Items]
Number of warrants issued to purchase the shares (in shares)			83,333
Common shares \| Public Offering
Class of Stock [Line Items]
Number of warrants issued to purchase the shares (in shares)			3,552,372
Issuance of common stock (in shares)			244,181
Class C Warrant
Class of Stock [Line Items]
Issuance of Common Stock from Warrant Exercises (in shares)								911
Class C Warrant \| Public Offering
Class of Stock [Line Items]
Number of warrants issued to purchase the shares (in shares)			638,889
Class C Warrants, Exercise of Option \| Over-Allotment Option
Class of Stock [Line Items]
Number of warrants issued to purchase the shares (in shares)			83,333
Class D Warrant \| Public Offering
Class of Stock [Line Items]
Number of warrants issued to purchase the shares (in shares)			638,889
Class D Warrant, Exercise Of Option \| Over-Allotment Option
Class of Stock [Line Items]
Number of warrants issued to purchase the shares (in shares)			83,333
Class C and Class D Warrants \| Public Offering
Class of Stock [Line Items]
Exercise price (in usd per share) \| $ / shares		$ 4.7079	$ 9.90
Warrants exercise price reduction, trading days, threshold, immediately following initial exercise day \| day		60
Exercise price reduction percentage of average of the VWAP for trading day period immediately prior to reset date		90.00%
Warrants exercise price reduction, trading days, threshold, prior to reset date \| day		5
909 Class C and 909 Class D Warrants \| Series F Convertible Preferred Stock \| Public Offering
Class of Stock [Line Items]
Purchase price (in usd per share) \| $ / shares			$ 8,999
Class D Warrants
Class of Stock [Line Items]
Exercise price (in usd per share) \| $ / shares						$ 4.7079	$ 4.7079
Issuance of Common Stock from Warrant Exercises (in shares)						53,213	203,934	911
Exercise of Warrants \| $						$ 300,000	$ 1,000,000.0
Class C Warrants
Class of Stock [Line Items]
Exercise price (in usd per share) \| $ / shares							$ 4.7079
Issuance of Common Stock from Warrant Exercises (in shares)							101,684
Exercise of Warrants \| $							$ 400,000
Maxim Group LLC
Class of Stock [Line Items]
Sale of stock, number of shares issued in transaction (in shares)	1,755,556
Net proceeds \| $	$ 13,800,000
Maxim Group LLC \| Pre Funded Warrants
Class of Stock [Line Items]
Number of warrants issued to purchase the shares (in shares)	1,261,582
Maxim Group LLC \| Tranche A Warrants and Tranche B Warrants
Class of Stock [Line Items]
Number of warrants issued to purchase the shares (in shares)	5,486,066
Maxim Group LLC \| Tranche A Warrants
Class of Stock [Line Items]
Number of warrants issued to purchase the shares (in shares)	2,743,033
Exercise price (in usd per share) \| $ / shares	$ 5.4684
Proceeds from issuance of warrants \| $	$ 15,000,000.0
Class of warrant or right, threshold trading days \| day	30
Class of warrant or right, volume weighted average price of common stock (in usd per share) \| $ / shares	$ 9.9432
Class of warrant or right, threshold consecutive trading days \| day	30
Warrants and rights outstanding, term	5 years
Maxim Group LLC \| Tranche B Warrants
Class of Stock [Line Items]
Number of warrants issued to purchase the shares (in shares)	2,743,033
Exercise price (in usd per share) \| $ / shares	$ 5.4684
Proceeds from issuance of warrants \| $	$ 15,000,000.0
Class of warrant or right, threshold trading days \| day	30
Class of warrant or right, volume weighted average price of common stock (in usd per share) \| $ / shares	$ 12.4290
Class of warrant or right, threshold consecutive trading days \| day	30
Warrants and rights outstanding, term	5 years
Lincoln Park
Class of Stock [Line Items]
Proceeds from issuance of common stock, net of offering costs \| $				$ 100,000								$ 300,000
Lincoln Park \| Common Stock
Class of Stock [Line Items]
Issuance of common stock (in shares)				2,222								11,667
Equity line of credit (up to) \| $					$ 10,000,000.0